Premium
p16 INK4a —Is the future of cervical cancer screening rosy?
Author(s) -
Moriarty Ann T.
Publication year - 2012
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21206
Subject(s) - papanicolaou stain , medicine , cervical cancer , triage , papanicolaou test , meta analysis , cancer , oncology , psychiatry
The author comments on a meta‐analysis in this issue regarding cyclin‐dependent kinase inhibitor 2A (p16 INK4a ) and the triage of women who have minimally abnormal Papanicolaou tests. The meta‐analysis provides a framework for future research; however, the method is not currently ready for widespread clinical use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom